| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
8.93 -0.22 (-0.02%) |
01-18 16:00 |
|
Open: |
9.16 |
Pre close: |
9.15 |
Target:
|
11.82
|
|
High: |
9.19 |
Low: |
8.84 |
Resistance:
|
10.12
11.82
|
|
Volume: |
302,996 |
Market Cap: |
531M |
Support:
|
7.77
6.31
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.25
 |
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
8.51  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
10.17 |
Stochastic Oscillator |
%K(14,3):
|
66.03 |
|
MA(250): |
11.70 |
%D(3): |
74.01 |
|
Average Volume(K) |
3-Month: |
59893
|
52-Week |
High:
|
15.59 |
|
10-Days: |
40985 |
Low: |
6.31 |
|
RSI |
RSI(14):
|
50.91 |
Change(%): |
-14.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-42.3 |
Shares Out. (M) |
59.44 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-37.8 |
Shares Float (M) |
59.04 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.70 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
122.80 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.080 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-41.41 |
P/S |
5307992064.00 |
|
Operating Margin |
-1031.42 |
Levered Free Cash Flow
(M) |
-27.47 |
P/CF |
-12.82 |
|
|
|
|
|
|
